Fresenius Medical Care AG & Co. KGaA (FMS)

Last Price$22.9(1.2%)

Market Cap$13.5B

LTM Operating Income

$1,674.9M

YoY Growth

+90.4%

3Y CAGR

-9.1%

5Y CAGR

-8.1%

Stock quality & Intrinsic value

6/10

123.9% undervalued

FMS

is 123.9% undervalued

learn more -->

50+

undervalued stocks

Start beating the S&P 500

Fresenius Medical Care AG & Co. KGaA Operating Income

Annual

Quarterly

LTM

Crunching data... Almost there!

	Dec'04	Dec'05	Dec'06	Dec'07	Dec'08	Dec'09	Dec'10	Dec'11	Dec'12	Dec'13	Dec'14	Dec'15	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23
Operating Income	$782.3M	$987.1M	$1,254.4M	$1,485.6M	$1,766.9M	$1,708.9M	$1,919.4M	$2,228.4M	$2,156.9M	$2,170.4M	$2,463.8M	$2,363.4M	$2,775.6M	$2,667.3M	$3,587.1M	$794.8M	$603.9M	$356.4M	($272.3M)	$1,480.9M

FMS

Key metrics and insights to make informed decisions.

View full analysis

Overvalued or undervalued?

Check the intrinsic value for FMS and see if it's the right time to invest.

Dive in

Fresenius Medical Care AG & Co. KGaA (FMS) Operating Income comparison analysis

Crunching data... Almost there!

FMS key stats

USD

EUR

Millions

Billions

Annual

Quarterly

Trailing

Key stats

Income statement

Balance sheet

Cash Flow Statement

Valuation

Ratios

Per share

Per employee

Dividends & Yields

Crunching data... Almost there!

Discover more Stock Ideas

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%

S&P Outperformance 19.1%

Next 3M Predicted Return 20.3%

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%

S&P Outperformance 22.3%

Next 3M Predicted Return 26.8%

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.

3M Return 28.4%

S&P Outperformance 15.4%

Next 3M Predicted Return 16.9%

More ideas -->

FAQ

1) What is Fresenius Medical Care AG & Co. KGaA's Operating Income?

As of today, Fresenius Medical Care AG & Co. KGaA's last 12-month Operating Income is $1,674.9M, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Fresenius Medical Care AG & Co. KGaA's Operating Income growth rate?

Over the last year, Fresenius Medical Care AG & Co. KGaA's Operating Income growth was 90.4%. The average annual Operating Income growth rates for Fresenius Medical Care AG & Co. KGaA have been (13.6%) over the past three years, (8.1%) over the past five years.

3) Is Fresenius Medical Care AG & Co. KGaA's Operating Income growth rate Good?

Over the last year, Fresenius Medical Care AG & Co. KGaA's Operating Income growth was 90.4%, which is higher than industry growth of (0.0%). It indicates that Fresenius Medical Care AG & Co. KGaA's Operating Income growth is Good.

4) How does Fresenius Medical Care AG & Co. KGaA's Operating Income growth rate compare to its peers?

Over the last year, Fresenius Medical Care AG & Co. KGaA's Operating Income growth was 90.4%, which is higher than peer median growth of (21.6%). The list of peers includes HCA, THC, DVA, UHS, EHC, ACHC, CHE, ENSG, OPCH, AMED etc.